Global Tobacco and Nicotine Forum 2017

This page was last edited on at

The Global Tobacco and Nicotine Forum (GTNF) is an annual tobacco industry conference.
The GTNF 2017 was held in September in New York, USA.1
Speakers included:

  • Tony Abboud – Executive director of the Vapor Technology Association (VTA)
  • David Abrams – Professor in the department of social and behavioural science at the New York University College of Global Public Health
  • Michael Arnold – Next Generation Labs (which develops synthetic nicotine)
  • Annette Bachand Ramboll Environ – Epidemiologist and biostatistician at Ramboll Environ, an environmental, safety and health sciences consulting firm
  • Marcella Ballard – Partner at law firm Venable LLP
  • Scott Ballin – Former vice president of the American Heart Association. Adviser to the University of Virginia
  • Patrick Basham – Director The Democracy Institute
  • Clive Bates – Founder of consulting and advocacy practice Counterfactual
  • Guy Bentley – Consumer freedom research associate at American think tank Reason Foundation
  • Paul Blair – Strategic initiatives director, Americans for Tax Reform, an organisation with a history of lobbying for tobacco companies2
  • Erik Bloomquist – Senior analyst global consumer staples, Haitong Securities
  • Oscar Camacho – Scientific data and statistics manager at British American Tobacco
  • Christopher Casey – Senior Vice President and general counsel of Swisher International, a manufacturer of cigars and smokeless tobacco
  • Alex Clark – Executive director of Consumer Advocates for Smoke-Free Alternatives Association (CASAA)
  • Simon Clark – Director of the tobacco industry funded group Forest. Clark ran several pro-tobacco campaigns including Hands Off Our Packs (2012) and No Thank EU (2013), and established the tobacco industry front group Action on Consumer Choice.
  • Tanya Cobb – Director, University of Virginia’s Institute for Environmental Negotiation
  • Gal Cohen – Vapour company PAX Labs
  • William Kerr Collins – New Carolina State University
  • Debra Crew – President and CEO of Reynolds American (RAI)
  • Linda Crumpler – Business development director for Cerulean, a UK-based company that manufactures measuring equipment to the tobacco industry
  • Michael Cummings – Professor in the department of psychiatry and behavioural sciences at the Hollings Cancer Center in South Carolina, United States (US)
  • Geoff Curtin – Senior director regulatory affairs at RAI Services Company
  • Sinclair Davidson – Professor of institutional economic at the Melbourne’s RMIT University
  • Ashley Davis – Works at American law firm Blank Rome and serves as liaison with the company’s strategic partner, Brussels-based public affairs consultancy Interel
  • Stacy Ehrlich – Partner at law firm Kleinfeld, Kaplan Becker (KBB Law)
  • Amy Fairchild – Professor and associate dean of academic affairs at the Public Health Texas A&M University
  • Konstantinos Farsalinos- Cardiologist working for the Department of Pharmacology at University of Patras and Department of Cardiology at Onassis Cardiac Surgery Center
  • Jonathan Fell – Tobacco industry analyst and founding partner of Ash Park
  • Mark Firestone – Senior vice president and general counsel, Philip Morris International
  • Marina Foltea – Founder and managing director of Trade Pacts, a Swiss-based trade and investment consultancy
  • Mark Goodwin – System director for innovation and structural heart, at Midwest Heart Specialists (now Advocate Medical Group)
  • Robyn Gougelet – Senior associate at American health consultancy Pinney Associates
  • Matthew Grainger – Executive director US/European tobacco and US food research, Morgan Stanley
  • Christopher Greer – President and CEO of the US-based Tobacco Merchants Association (TMA) and department head of corporate affairs and communications of Japan Tobacco International USA
  • Summer Hanna – Director of scientific and regulatory affairs, RAI Services Company
  • Dorothy Hatsukami – Professor of psychiatry and Forster Family Chair in cancer prevention at the Masonic Cancer Center of the University of Minnesota
  • Hugh Haydon – President of Kentucky BioProcessing (KBP), a RAI company
  • Jack Hennigfield – Vice President Research, Health Policy and Abuse Liability at Pinney Associates
  • Bonnie Herzog – Tobacco industry analyst at Wells Fargo
  • John Hood – Director of operations and investigations at LLS Consulting, a management consulting company
  • Michael Hufford – Vice president for Regulatory Affairs Behavioural Science and Innovation at Pinney Associates
  • Duncan Hunter – Republican US Congressman, representing California’s 50th congressional district
  • Damon Jacobs – Associate fellow (with an interest in tobacco harm reduction at the American think tank R Street Institute
  • Ian Jones – Reduced risk products vice president, Japan Tobacco International
  • Julian Kinderlerer – A chemist and professor of intellectual property law, an associate of SciCom, and member of the European Group on Ethics in Science and New Technologies
  • Mark Kleiman – Professor of public policy at New York University’s Wagner School of Public Service, and chairman of research consulting firm BOTEC Analysis (which produced research reports for Altria – see our page on PMI IMPACT)
  • Patricia Kovacevic – General counsel and chief compliance officer for e-liquid and e-cigarette manufacturer Nicopure Labcs
  • Christopher Leighton – Associate professor of history at the Massachusetts Institute of Technology
  • Kgosi Letlape – President of the Health Professions Council of South Africa (HPSCA) and former chairman of the South African Medical Association
  • David Levy – Professor of oncology at Georgetown University
  • Mike Ligon – Vice President corporate affairs for Universal Corporation (parent company of Universal Leaf Tobacco Company)
  • Mark Littlewood – Director general of libertarian think tank Institute of Economic Affairs (IEA)
  • Rolf Lutz – Director of product policy at Philip Morris International
  • Derek Mariner – Principal scientist in the Analytical Development Center of British American Tobacco
  • LeAnne Moore – Assistant general counsel at Turning Point Brands, which manufactures smokeless tobacco and smoking tobacco in the US
  • Jose Luis Murillo – Vice President of regulatory affairs for Altria Client Services
  • James Murphy – Head of reduced risk substantiation at British American Tobacco
  • Ray Niaura – Professor of social and behavioural science at New York University’s College of Global Public Health, adjunct professor in the department of health, behaviour and society at the Johns Hopkins Bloomberg School of Public Health, and an adjunct professor in the department of oncology at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
  • David O’Reilly – Scientific director and R&D director of British American Tobacco
  • Zahia Ouar – Head of product compliance and stewardship at Schweitzer-Mauduit International (SWM), a company that supplies paper, wrappers and filters to tobacco manufacturers
  • Riccardo Polosa – Professor of internal medicine and head of the Institute of Internal and Emergency Medicine at the University of Catania
  • Giles Roca – Director general of the UK Tobacco Manufacturers’ Association
  • Christopher Russell – Behavioural psychologist and senior research fellow at the Glasgow-based Centre for Substance Use Research
  • Sam Salaymeh – President and CEO of North American of AMV Holdings, a manufacturer and distributor of vapour products
  • Mohamadi Sarkar – Senior principal scientist for Altria Client Services
  • Sally Satel – resident scholar of the American Enterprise Institute (AEI), a rightwing think tank with a reported history of working for the tobacco industry3
  • Audrey Silk -Founder of New York smokers’ rights group Citizens Lobbying Against Smoker Harassment (CLASH)
  • Jim Solyst – Vice President of federal regulatory affairs for Swedish Match North America
  • Irina Stepanov – Associate professor environmental health sciences of School of Public Health at the University of Minnesota
  • Jeff Stier – Senior fellow at the National Center for Public Policy Research
  • David Sweanor – University of Ottawa
  • Florian Teischinger – Data scientist at Japan Tobacco International
  • Marina Trani – Head of research and development for next generation products at Nicoventures, British American Tobacco
  • Eve Wang – Marketing director of Shenzhen Smoore Technology Company, manufacturer of e-cigarette brand Vaporesso
  • Shelly Weitz – Consultant at Weitz Marketing
  • Kingsley Wheaton – Director of next generation products at British American Tobacco
  • Rupert Wilson- Owner and managing director of UK-based Strategic Business Consulting
  • Derek Yach – Founder of the Foundation for a Smoke-Free World, previously chief health officer of the Vitality Group
  • Mitch Zeller – Director of the Center for Tobacco Products at the Food and Drug Administration (FDA)

TobaccoTactics Resources

Print Friendly, PDF & Email


  1. Global Tobacco & Nicotine Forum, Look who’s talking, 2017, accessed October 2017
  2. Sourcewatch, Americans for Tax Reform and Big Tobacco, last updated 11 October 2017, accessed January 2018
  3. Sourcewatch, American Enterprise Institute, last updated 11 October 2017, accessed January 2018